GPGA
WX

Grandeur Peak Global Advisors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Grandeur Peak Global Advisors’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-396,743
Closed -$17.1M – 130
2015
Q3 		$17.1M Sell
396,743
-21,725
-5% -$917K 3.83% 4
2015
Q2 		$17.7M Buy
418,468
+73,950
+21% +$3.12M 3.49% 3
2015
Q1 		$13.4M Sell
344,518
-44,292
-11% -$1.71M 2.83% 5
2014
Q4 		$13.1M Buy
388,810
+30,425
+8% +$1.07M 2.94% 6
2014
Q3 		$12.6M Buy
358,385
+63,350
+21% +$2.17M 3.05% 5
2014
Q2 		$9.7M Buy
295,035
+31,900
+12% +$1.09M 2.09% 8
2014
Q1 		$9.7M Buy
263,135
+32,750
+14% +$1.2M 2.29% 7
2013
Q4 		$8.84M Buy
230,385
+20,185
+10% +$637K 2.36% 7
2013
Q3 		$5.76M Buy
210,200
+36,700
+21% +$870K 1.6% 14
2013
Q2 		$3.64M Buy
+173,500
New +$3.39M 1.4% 20

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Grandeur Peak Global Advisors's WX Position: Q4 2015 in Review

Grandeur Peak Global Advisors sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 396,743 shares — an estimated $17.1M sold.

Grandeur Peak Global Advisors first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $17.7M in Q2 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Grandeur Peak Global Advisors reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Grandeur Peak Global Advisors sold 396,743 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $17.1M.
  • Grandeur Peak Global Advisors first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • Grandeur Peak Global Advisors's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $17.7M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Grandeur Peak Global Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.